Case Study

Crouse Hospital boasts a nationally recognized cardiac care center, providing a full range of interventional and diagnostic procedures for pediatric and adult patients in the greater Syracuse, N.Y., area. Its robust program requires state-of-the-art technology. Crouse recently implemented HealthView, a Web-based cardiovascular information system (CVIS) by Lumedx that streamlines clinical workflows and improves access to patient information across the care continuum.

Home April 08, 2013
Home
News

Atomic Energy of Canada Limited (AECL) will commence a 30-day planned shutdown for inspection and maintenance of the National Research Universal (NRU) reactor at Chalk River, Ontario, starting April 14, 2013. This planned shutdown, which AECL has advised will last until May 14, 2013, will result in an interruption in the supply of medical isotopes used in nuclear imaging procedures in the United States. Chalk River is one of the primary sources for the isotopes used in nuclear imaging radiopharmaceuticals.

Home April 08, 2013
Home
Technology

A study led by researchers at the University of North Carolina indicates a newly approved blood thinner blocks a key component of the human blood clotting system and may increase the risk and severity of certain viral infections, including flu and myocarditis.

Home April 05, 2013
Home
News

One of the leading complaints in the emergency department is chest pain and the timely detection of a heart attack is essential. The Johns Hopkins Hospital presented an abstract at the American College of Cardiology (ACC) conference in March that utilized VentraCor's VectraplexECG System. The abstract, entitled "New Cardiac Electrical Biomarker Measured on 12-Lead ECG Strongly Correlates With High Sensitivity Troponin in Patients Admitted to the Emergency Department to Rule Out Acute Myocardial Ischemic Injury," was presented by Larisa Tereshchenko, M.D., Ph.D., FAHA, of The Johns Hopkins Hospital.

Home April 05, 2013
Home
News

Continuing its commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism (PE), Argon Medical Devices Inc. launched the OptionELITE Retrievable Vena Cava Filter. The OptionELITE IVC Filter, designed by Rex Medical LP, provides the clinician with the same safe and trusted design now enhanced for ease of delivery and retrievability.

Home April 05, 2013
Home
Technology

Toshiba America Medical Systems Inc. has introduced the Aplio 500 and Aplio 300 CV ultrasound systems to help clinicians more accurately and efficiently diagnose cardiovascular disease. Compact and easy-to-use, Aplio 500 CV and Aplio 300 CV deliver exceptional image quality and advanced technologies to improve patient diagnoses and treatment.

Home April 05, 2013
Home
Technology

Siemens Healthcare has introduced a new version of its cardiovascular imaging and information system. From routine to advanced readings, the new version of syngo Dynamics helps streamline workflows and optimize clinical utilization.

Home April 04, 2013
Home
Technology

Corgenix Medical Corp. has announced that Atherotech Diagnostics Lab will carry its AspirinWorks Test for determining aspirin effect.

Home April 04, 2013
Home
Technology

SunTech Medical has updated its line of automated blood pressure (BP) monitoring with the Tango M2 cardiac stress BP monitor. The new product provides accurate BP measurements during exercise and cardiac stress testing where noise and motion often make manual measurements difficult.

Home April 04, 2013
Home
News

Endosense has announced that the results of its EFFICAS I prospective multi-center study have led to the development of guidelines for target and minimum contact force (CF), as well as minimum Force Time Integral (FTI), during the catheter ablation treatment of paroxysmal atrial fibrillation (PAF).

Home April 04, 2013
Home
News

iRhythm Technologies Inc. announced clinical study findings showing that use of the Zio Patch resulted in a change in treatment strategy for nearly one-third of patients with paroxysmal atrial fibrillation (AF). The data, which was published in Pacing and Clinical Electrophysiology (PACE) Journal on March 12, showed that the Zio Patch ambulatory cardiac monitoring system demonstrated improved clinical accuracy and detection of potentially malignant arrhythmias in AF patients compared with a 24-hour Holter monitor in the same patients.

Home April 04, 2013
Home
CHAMPION PHOENIX clinical study anti-platelet therapy cangrelor ACC 13
Feature

The experimental anti-clotting drug cangrelor solidly outperformed commonly used clopidogrel in a large global trial of patients who underwent coronary stent procedures, according to data from the phase III CHAMPION PHOENIX study presented at the American College of Cardiology’s 62nd Annual Scientific Session.

Home April 04, 2013
Home
News

BioControl Medical has received U.S. Food and Drug Administration (FDA) approval to begin the third and largest phase of INOVATE-HF (INcrease Of VAgal TonE in Heart Failure), a global, multi-center, investigational device exemption (IDE) clinical study of the company’s CardioFit system for heart failure. The approval, which is based on the FDA’s safety review of the first two successful completed phases, allows unconditional study expansion to full enrollment of 650 patients at 80 centers worldwide.

Home April 03, 2013
Home
News

An RTI International-developed prototype catheter that can generate live, streaming 3-D ultrasound images from inside the heart received a Cardiovascular Innovation Award at the 2013 Cardiovascular Research Technologies Annual Symposium.

Home April 03, 2013
Home
Cardiac Science, Mortara, Burdick, ECG
Feature

Cardiac Science is selling its diagnostic cardiology product line to Mortara Instrument Inc. The business consists of the Burdick and Quinton brands and associated products. The transaction does not include MySense, the novel, wearable, single-patient ECG recorder system or the resuscitation business unit, which markets automated external defibrillators (AEDs) worldwide.

Home April 02, 2013
Home
Subscribe Now